company background image
OCPH logo

October PharmaE CASE:OCPH Stock Report

Last Price


Market Cap







23 Jun, 2024


Company Financials

OCPH Stock Overview

Manufactures and sells pharmaceutical products in Egypt.

OCPH fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health5/6

October Pharma S.A.E Competitors

Price History & Performance

Summary of all time highs, changes and price drops for October PharmaE
Historical stock prices
Current Share Priceج.م100.00
52 Week Highج.م120.00
52 Week Lowج.م80.00
11 Month Change0%
3 Month Change0%
1 Year Change0%
33 Year Change110.44%
5 Year Change177.09%
Change since IPO2,005.26%

Recent News & Updates

Recent updates

Shareholder Returns

OCPHEG PharmaceuticalsEG Market

Return vs Industry: OCPH underperformed the EG Pharmaceuticals industry which returned 20.5% over the past year.

Return vs Market: OCPH underperformed the EG Market which returned 47% over the past year.

Price Volatility

Is OCPH's price volatile compared to industry and market?
OCPH volatility
OCPH Average Weekly Movement0%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement7.3%
10% most volatile stocks in EG Market10.5%
10% least volatile stocks in EG Market3.7%

Stable Share Price: OCPH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine OCPH's volatility change over the past year.

About the Company


October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

October Pharma S.A.E Fundamentals Summary

How do October PharmaE's earnings and revenue compare to its market cap?
OCPH fundamental statistics
Market capج.م1.20b
Earnings (TTM)ج.م157.30m
Revenue (TTM)ج.م1.07b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OCPH income statement (TTM)
Cost of Revenueج.م554.52m
Gross Profitج.م518.89m
Other Expensesج.م361.59m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)13.11
Gross Margin48.34%
Net Profit Margin14.65%
Debt/Equity Ratio54.5%

How did OCPH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.